107 related articles for article (PubMed ID: 2963855)
1. Prothymosin alpha restores the depressed autologous and allogeneic mixed lymphocyte responses in patients with systemic lupus erythematosus.
Baxevanis CN; Reclos GJ; Papamichail M; Tsokos GC
Immunopharmacol Immunotoxicol; 1987; 9(4):429-40. PubMed ID: 2963855
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of prothymosin alpha in the human autologous mixed lymphocyte response.
Baxevanis CN; Reclos GJ; Economou M; Arsenis P; Katsiyiannis A; Seferiades K; Papadopoulos G; Tsolas O; Papamichail M
Immunopharmacol Immunotoxicol; 1988; 10(4):443-61. PubMed ID: 2977606
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis.
Reclos GJ; Baxevanis CN; Sfagos C; Papageorgiou C; Tsokos GC; Papamichail M
Clin Exp Immunol; 1987 Nov; 70(2):336-44. PubMed ID: 2962790
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of human T lymphocyte functions by prothymosin alpha. I. Augmentation of mixed lymphocyte culture reactions and soluble protein-induced proliferative responses.
Baxevanis CN; Reclos GJ; Panneerselvam C; Papamichail M
Immunopharmacology; 1988; 15(2):73-84. PubMed ID: 2967267
[TBL] [Abstract][Full Text] [Related]
5. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
6. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of human T lymphocyte function by prothymosin alpha: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes.
Baxevanis CN; Frillingos S; Seferiadis K; Reclos GJ; Arsenis P; Katsiyiannis A; Anastasopoulos E; Tsolas O; Papamichail M
Immunopharmacol Immunotoxicol; 1990; 12(4):595-617. PubMed ID: 2092041
[TBL] [Abstract][Full Text] [Related]
8. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
[TBL] [Abstract][Full Text] [Related]
9. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin alpha 1 enhances while thymosin beta 4 suppresses the human autologous and allogeneic mixed lymphocyte reaction.
Baxevanis CN; Reclos GJ; Perez S; Kokkinopoulos D; Papamichail M
Immunopharmacology; 1987 Apr; 13(2):133-41. PubMed ID: 2954929
[TBL] [Abstract][Full Text] [Related]
11. Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus.
Sakane T; Steinberg AD; Green I
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3464-8. PubMed ID: 150602
[TBL] [Abstract][Full Text] [Related]
12. Prothymosin alpha restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer.
Baxevanis CN; Reclos GJ; Papamichail M
Int J Cancer; 1993 Jan; 53(2):264-8. PubMed ID: 8425763
[TBL] [Abstract][Full Text] [Related]
13. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
14. The autologous mixed lymphocyte reaction in patients with rheumatoid arthritis.
Kalden JR; Leitner O; Klöckel O; Kirchner H; Manger B; Koch B
Behring Inst Mitt; 1983 May; (72):193-202. PubMed ID: 6085746
[TBL] [Abstract][Full Text] [Related]
15. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
Smolen JS; Siminovitch K; Luger TA; Steinberg AD
Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
17. [The dysfunction of human peripheral blood dendritic cells on concanavalin A-induced T cell responses in patients with systemic lupus erythematosus].
Katagiri T
Arerugi; 1992 Jun; 41(6):693-8. PubMed ID: 1444821
[TBL] [Abstract][Full Text] [Related]
18. Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.
Huber C; Pfister R; Stingl G
Clin Exp Immunol; 1982 Dec; 50(3):525-33. PubMed ID: 6219834
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus.
Tsokos GC; Smith PL; Christian CB; Lipnick RN; Balow JE; Djeu JY
Clin Immunol Immunopathol; 1985 Mar; 34(3):379-86. PubMed ID: 3156017
[TBL] [Abstract][Full Text] [Related]
20. Prothymosin alpha enhances human and murine MHC class II surface antigen expression and messenger RNA accumulation.
Baxevanis CN; Thanos D; Reclos GJ; Anastasopoulos E; Tsokos GC; Papamatheakis J; Papamichail M
J Immunol; 1992 Apr; 148(7):1979-84. PubMed ID: 1545115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
